Volume 14 • Issue 8 • August 2020 ISSN 1814 3601

Figure 1. Incidence rate of measles cases with rash onset 1–31 July 2020, WHO Western Pacific Region

Pacific island countries and areas

DISCLAIMER: The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved *Map of Australia is from the Australian Bureau of Statistics

Table 1. Numbers of confirmed and total (confirmed and compatible) measles cases by month of rash onset, February–July 2020, WHO Western Pacific Region

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 August 2020

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

No. of confirmed

Total no. of cases

Australia1 4 4 0 0 0 0 0 0 0 0 0 0Brunei Darussalam 0 0 0 0 0 0 0 0 0 0 0 0Cambodia 163 163 63 63 31 31 6 6 12 12 4 4China 46 53 44 48 48 52 58 62 59 62 65 91China, Hong Kong SAR 0 0 1 1 0 0 0 0 0 0 0 0China, Macao SAR 0 0 0 0 0 0 0 0 0 0 0 0Japan 4 4 1 1 0 1 2 2 0 0 0 0Lao People's Democratic Republic 24 24 6 6 0 0 4 5 0 0 0 0Malaysia 103 105 89 98 28 29 12 13 24 25 21 21Mongolia 0 0 0 0 0 0 0 0 0 0 0 0New Zealand 0 0 0 0 0 0 0 0 0 0 0 0Papua New Guinea 1 1 0 0 0 1 0 0 0 0 0 0Philippines 343 1224 75 624 5 138 2 49 4 36 0 12Republic of Korea 3 3 0 0 0 0 0 0 0 0 0 0Singapore 2 2 3 3 0 1 0 0 0 1 0 0Viet Nam 78 129 30 51 10 19 11 19 3 9 1 3Pacific island countries and areas 2 2 1 1 0 0 0 0 0 0 0 0Western Pacific Region 773 1714 313 896 122 272 95 156 102 145 91 1311 Reports only confirmed cases

Jun2020

Mar JulCountry/area

MayFeb Apr

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 August 2020

Figure 2. Total (confirmed and compatible) measles cases by month of rash onset, WHO Western Pacific Region, 2015–2020 as of 20 August 2020

0

2 000

4 000

6 000

8 000

10 000

12 000

14 000

16 000

18 000Ja

nFe

bM

ar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

Aug

Sep

Oct

Nov

Dec

Jan

Feb

Mar Apr

May Jun Jul

2015 2016 2017 2018 2019 2020

Num

ber o

f mea

sles

cas

es

China Malaysia Mongolia Papua New Guinea Philippines Viet Nam Others

Source: Measles and rubella monthly country reports to WHO by 20 August 2020

Table 2. Status of verification of measles elimination, WHO Western Pacific Region

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 August 2020

Imported Import-related Endemic

Unknown/ not

reportedImported Import-

related EndemicUnknown

/ not reported

Australia 2014 285 106 149 0 30 89.5% 25 12 4 0 9 64.0%Brunei Darussalam 2015 1 1 0 0 0 100.0% 0 - - - - -Cambodia 2015 676 0 0 0 679 0.0% 363 0 0 0 363 0.0%China - 2 990 0 0 0 2 990 0.0% 466 0 0 0 466 0.0%China, Hong Kong SAR 2016 90 39 42 0 9 90.0% 1 0 0 0 1 0.0%China, Macao SAR 2014 36 18 17 0 0 97.2% 0 - - - - -Japan 2015 737 116 500 0 121 83.6% 10 3 1 0 6 40.0%Lao People's Democratic Republic - 1 037 0 0 0 785 0.0% 104 0 0 0 104 0.0%Malaysia - 1 050 5 0 854 191 81.8% 352 1 0 315 36 89.8%Mongolia - 2 0 0 0 2 0.0% 0 - - - - -New Zealand 2017 2 173 28 469 0 1 680 22.9% 7 1 3 0 3 57.1%Papua New Guinea - 1 0 0 0 1 0.0% 2 0 0 0 2 0.0%Philippines - 6 792 255 14 4 995 1 528 77.5% 894 53 0 625 216 75.8%Republic of Korea 2014 190 86 101 0 3 98.4% 6 6 0 0 0 100.0%Singapore 2018 152 33 2 0 117 23.0% 10 2 0 0 8 20.0%Viet Nam - 3 300 0 0 0 3 300 0.0% 221 0 0 0 221 0.0%Pacific island countries and areas - 6 346 0 0 0 6 346 0.0% 74 0 0 0 74 0.0%Total 25 858 687 1 294 5 849 17 782 30.3% 2 535 78 8 940 1 509 40.5%

Blue No measles casesGreen ≥80%Yellow 60–79%Red <60%

Source of infection % of cases with known

source of infection

Country/area Year verified

2020

No. of confirmed

cases

Source of infection % of cases with known

source of infection

2019

No. of confirmed

cases

2

3

Table 3. Measles case classification and incidence by country and area, WHO Western Pacific Region, 2016—2020 as of 20 August 2020

Clinically compatible Lab Epi-

linked

Total confirmed

and clinically

compatible1

Annualized measles

incidence per 1 million pop.

Australia 99 4.1 81 3.3 101 4.1 285 11.3 31-Dec-19 25.5 NA3 0 0 0 25 0 25 1.7 0 26-Feb-20

Brunei Darussalam 1 2.4 0 0.0 1 2.3 1 2.3 13-Sep-19 0.4 9 0 9 0 0 0 0 0.0 0 13-Sep-19

Cambodia 56 3.6 10 0.6 3 0.2 676 41.0 29-Dec-19 16.7 2 072 81 1 628 0 363 0 363 37.2 0 13-Aug-20

China 24 839 17.6 5 993 4.2 3 975 2.8 3 098 2.2 31-Dec-19 1439.3 11 658 497 10 643 52 465 1 518 0.6 0 31-Jul-20

China, Hong Kong SAR 9 1.2 4 0.5 16 2.2 90 12.1 1-Dec-19 7.5 4 0 3 0 1 0 1 0.2 0 24-Mar-20

China, Macao SAR 0 0.0 2 3.2 3 4.7 36 56.2 6-May-19 0.6 5 0 5 0 0 0 0 0.0 0 6-May-19

Japan 163 1.3 188 1.5 279 2.2 761 6.0 28-Dec-19 126.5 417 18 214 1 10 0 11 0.1 0 13-May-20

Lao People's Democratic Republic 8 1.2 3 0.4 10 1.4 1 119 156.1 30-Dec-19 7.3 260 12 140 4 36 68 108 25.4 0 24-May-20

Malaysia 1 587 51.7 1 693 54.4 1 958 62.1 1 077 33.7 29-Dec-19 32.4 3 898 255 3 275 16 351 1 368 19.5 0 24-Jul-20

Mongolia 28 813 9427.2 9 2.9 1 0.3 2 0.6 4-Mar-19 3.3 64 0 64 0 0 0 0 0.0 0 4-Mar-19

New Zealand 104 22.3 15 3.2 36 7.6 2 229 466.0 30-Dec-19 4.8 207 0 171 0 6 1 7 2.5 0 29-Jan-20

Papua New Guinea 0 0.0 7 0.8 15 1.7 1 0.1 6-Aug-18 8.9 108 2 99 1 2 0 3 0.6 0 6-Feb-20

Philippines 641 6.2 2 432 23.1 22 869 214.4 48 521 448.8 6-Dec-19 109.6 4 462 0 909 2 659 755 139 3 553 55.6 10 28-Jun-20

Republic of Korea 18 0.4 7 0.1 19 0.4 191 3.7 20-Aug-19 51.3 206 0 200 0 6 0 6 0.2 0 10-Feb-20

Singapore 157 27.8 81 14.2 37 6.4 162 27.9 3-Dec-19 5.9 26 0 14 2 10 0 12 3.5 0 22-Mar-20

Viet Nam 368 3.9 592 6.3 1 249 13.1 5 004 51.9 8-Dec-19 97.3 1 527 756 180 98 219 2 319 5.6 0 13-Jul-20

Pacific island countries and areas4 6 1.9 2 0.6 0 0.0 6 346 1885.5 7-Feb-20 3.4 217 9 152 0 5 0 74 37.2 0 13-Jan-20

American Samoa - - - - - - 31 560.5 0.1 2 0 0 0 2 0 2 62.1 0 19-Jan-20

Fiji 5 5.7 1 1.1 0 0.0 31 34.8 1-May-17 0.9 166 9 152 0 5 0 5 9.6 0 5-Mar-20

New Caledonia - - 1 3.6 0 0.0 0 0.0 10-Jan-17 0.3 0 - - - - - - - - 10-Jan-17

Samoa - - - - - - 5 689 28864.5 13-Jan-20 0.2 - - - - - - 18 155.5 - 13-Jan-20

Solomon Islands 1 1.6 0 0.0 0 0.0 - - 21-Jan-16 0.7 0 - - - - - - - - 21-Jan-16

Tonga - - - - - - 608 5818.3 31-Dec-19 0.1 51 0 0 - - - 51 827.2 0 13-Feb-20

Western Pacific Region 56 869 29.9 11 119 5.8 30 572 15.9 63 284 32.8 1940.7 25 140 1 630 17 706 2 833 2 254 212 5 299 4.7 101 Includes clinically compatible, laboratory confirmed and epi-linked confirmed cases Green <1 confirmed measles case / 1 000 000 population2 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2019 revision. Yellow 1–9.9 confirmed measles case / 1 000 000 population3 Australia reports confirmed cases only. Red >= 10 confirmed cases / 1 000 000 population4 Classification is provisional based on laboratory data only.

2019

Total confirmed

and clinically compatible1

Measles incidence

per 1 million

pop.

Total confirmed and

clinically compatible1

Measles incidence

per 1 million

pop.

Rash onset of last

confirmed measles case

Total confirmed and

clinically compatible1

Measles incidence

per 1 million

pop.

2016

Total confirmed and

clinically compatible1

Measles incidence

per 1 million

pop.

20182017

Country/area

2020

Rash onset of last

confirmed measles

case

Population (in

millions) 2

Suspected measles

cases

Pending classification

Discarded cases3

Measles cases

Deaths due to

measles

3

4

Table 4. Measles surveillance performance indicators by country and area, WHO Western Pacific Region, 2019—2020 as of 20 August 2020

Discarded non-measles rate per

100 000 pop

Annualized discarded non-measles rate per 100

000 pop

≥ 2 ≥ 2

Australia 3 Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data Insufficient data

Brunei Darussalam 4.6 Not applicable 100.0% 95.2% 3.5 Not applicable 88.9% 88.9%

Cambodia 9.2 96.0% 91.3% 96.4% 16.7 100.0% 93.4% 98.2%

China 5.3 77.4% 96.8% 79.7% 1.3 6.5% 97.4% 89.3%

China, Hong Kong SAR 0.1 Not applicable 100.0% 90.8% 0.1 Not applicable 100.0% 100.0%

China, Macao SAR 14.5 Not applicable 97.7% 97.7% 1.3 Not applicable 100.0% 100.0%

Japan 2.1 23.4% Insufficient data Insufficient data 0.3 0.0% Insufficient data Insufficient data

Lao People's Democratic Republic 12.8 100.0% 85.2% 85.6% 3.3 50.0% 94.3% 97.4%

Malaysia 28.6 93.8% 84.8% 91.7% 17.3 93.8% 87.9% 98.1%

Mongolia 10.4 50.0% 94.4% 95.2% 3.3 22.7% 100.0% 100.0%

New Zealand 2.0 Insufficient data Insufficient data Insufficient data 6.1 65.0% Insufficient data Insufficient data

Papua New Guinea 1.0 15.0% 77.4% 88.2% 1.9 25.0% 83.3% 94.4%

Philippines 1.8 27.8% 29.6% 38.6% 1.4 11.1% 43.5% 49.2%

Republic of Korea 8.7 100.0% 87.2% 97.2% 0.7 0.0% 71.4% 89.8%

Singapore 1.9 Not applicable 73.1% 73.1% 0.4 Not applicable 80.8% 73.1%

Viet Nam 0.9 14.3% 26.8% 37.7% 0.3 4.8% 27.1% 57.2%

Pacific island countries and areas4 13.4 10.0% Insufficient data 87.0% 7.6 5.0% 47.5% 63.6%

Western Pacific Region 50.3 46.8% 66.6% 63.0% 29.1 25.2% 78.8% 80.1%Green Reached or surpassed target

Yellow Nearly reached target: 1.00–1.99 for non-measles suspected case rate; 10.1–25% for percent clinically confirmed cases; 60–79% for other indicators

Red Substantially below target

2020

Second level units with≥ 2 discarded cases per

100 000 pop [annualized]1

Suspected cases with adequate investigation

Suspected cases with adequate specimens for laboratory confirmation 2

≥ 80% ≥ 80% ≥ 80%≥ 80% ≥ 80%

Country/area

2019

Second level units with≥ 2 discarded cases per

100 000 pop [annualized]1

Suspected cases with adequate investigation

Suspected cases with adequate specimens for laboratory confirmation 2

≥ 80%

1 This indicator is not applicable for countries which have no second-level administrative units2 Adequate specimen defined as blood specimen collected within 28 days of rash onset or other specimen (throat swab, nasopharyngeal swab, cerebrospinal fluid, urine) collected within 5 days of rash onset; excludes epidemiologically-linked cases.3 Reports only confirmed cases4 Surveillance performance indicators refer to all the Pacific island countries and areas as one epidemiological block; each country is considered as second level unit

5

Table 5. Rubella case classification and incidence by country and area, WHO Western Pacific Region, 2016–2020 as of 20 August 2020

Clinically compatible

casesLab Epi-linked

Australia - - - - - - - - 25.40 - - - - - - - - -

Brunei Darussalam 0 0.0 0 0.0 0 0.0 0 0.0 0.44 9 0 9 0 0 0 0 0.0 -

Cambodia 4 0.3 7 0.4 3 0.2 30 1.8 16.72 2 072 143 1 905 0 24 0 24 2.5 -

China 4 476 3.2 1 601 1.1 3 935 2.8 32 568 22.9 1 424.55 11 658 497 9 537 348 1 106 170 1 624 2.0 -

China, Hong Kong SAR 3 0.4 1 0.1 11 1.5 48 6.4 7.55 4 0 0 0 4 0 4 0.9 -

China, Macao SAR 1 1.6 0 0.0 1 1.6 78 121.5 0.65 5 0 2 0 3 0 3 7.9 -

Japan3 3 0.0 5 0.0 68 0.5 2 394 18.9 126.50 277 8 181 7 80 1 88 1.2 -

Lao People's Democratic Republic 40 5.8 12 1.7 15 2.1 11 1.6 7.16 260 12 236 0 12 0 12 2.9 -

Malaysia 68 2.2 113 3.6 175 5.6 111 3.4 32.87 3 918 255 3 619 0 44 0 44 2.3 -

Mongolia 27 8.8 13 4.2 1 0.3 2 0.6 3.21 64 0 64 0 0 0 0 0.0 -

New Zealand - - - - - - 1 0.2 4.83 0 - - - - - - - -

Papua New Guinea 2 0.2 1 0.1 1 0.1 5 0.6 8.76 103 1 102 0 0 0 0 0.0 -

Philippines 165 1.6 448 4.3 152 1.4 198 1.8 109.70 4 462 0 4 099 0 353 10 363 5.7 -

Republic of Korea 3 0.1 2 0.0 0 0.00 8 0.2 51.51 57 0 55 0 2 0 2 0.1 -

Singapore 0 0.0 3 0.5 16 2.8 7 1.2 5.94 11 0 4 6 1 0 7 2.0 -

Viet Nam 350 3.7 126 1.3 102 1.1 85 0.9 98.36 265 57 182 15 11 0 26 0.5 -

Pacific island countries and areas2 1 0.3 4 1.2 0 0.0 0 0.0 3.40 166 9 157 0 0 0 0 0.0 -

Fiji 1 1.1 4 4.6 0 0.0 0 0.0 0.92 166 9 157 0 0 0 0 0.0 -

New Caledonia 0 0.0 0 0.0 0 0.0 0 0.0 0.29 0 - - - - - - - -

Solomon Islands - - 0 0.0 - - - - 0.65 0 - - - - - - - -

Vanuatu 0 0.0 - - - - - - 0.29 0 - - - - - - - -

Western Pacific Region 5 143 2.7 2 336 1.2 4 480 2.3 35 546 18.5 1927.54 23 331 982 20 152 376 1 640 181 2 197 2.0 -1 United Nations, Department of Economic and Social Affairs, Population Division World Population Prospects 2019 revision Green <1 confirmed measles case / 1 000 000 population

2 Classification is provisional based on laboratory data only. Yellow 1–9.9 confirmed measles case / 1 000 000 population

3 Rubella cases are cases reported as suspected measles cases that were identified as rubella laboratory confirmed cases during the investigation. This represents a small proportion of a large number of rubella cases occurring in Japan during 2018 Red >= 10 confirmed cases / 1 000 000 population

"-" No data Gray No data

2017

Annualized Rubella

incidence per 1 million pop.

Congenital rubella

syndrome

2018 2019

Investigated for rubella

Pending classification

Discarded cases

Rubella casesTotal

confirmed and clinically compatible

Total confirmed

and clinically compatible

Rubella incidence per 1 million pop.

Rubella incidence per 1 million pop.

Total confirmed

and clinically compatible

Rubella incidence per 1 million pop.

2020

Population (in millions) 1

Rubella incidence per 1 million pop.

2016

Total confirmed

and clinically compatible

Country/areaTotal

confirmed and clinically compatible

6

Table 6A. Measles and rubella laboratory testing, WHO Western Pacific Region, 2019

No. No. % No. %No.

receivedNo. (+)

No. of samples tested

No. of isolates

No. of samples tested

No. (+) No. No. % No. %

Australia VIDRL 225 225 195 14 12 85.7 0 0% 0 - 92.9 57 17 209 199 192 1 1 100% 0 0%

Brunei Darussalam DLS 24 22 22 22 2 9.1 1 5% 0 - 95.8 1 1 1 0 2 22 0 0% 0 0%

Cambodia NIPH 2 195 2 195 2 195 2 116 674 31.9 2 0% 79 1 83.6 0 - 0 - 675 2 191 30 1% 0 0%

China CCDC - - - - - - - - - - 95.8 - - - - - - - - - -

China, Hong Kong SAR PHLC 2 893 2 893 1 787 1 394 59 4.2 12 1% 0 - 98.8 87 36 1 425 108 110 414 43 10% 7 2%

China, Macao SAR PHL 829 829 507 506 31 6.1 9 2% 0 - 100.0 0 - 383 52 62 505 39 8% 17 3%

Japan NIID 10 633 10 481 6 164 677 206 30.4 86 13% 0 - No data 0 - 3 018 652 737 1 604 1 171 73% 66 4%

Lao People's Democratic Republic NCLE 1 013 1 013 1 013 1 008 152 15.1 18 2% 0 - 89.2 0 - 0 - 152 1 013 14 1% 25 2%

Malaysia NPHL 18 638 18 638 12 059 11 542 1 212 10.5 231 2% 0 - 92.0 5 048 22 0 - 1 120 9 790 375 4% 171 2%

Mongolia NCCD 338 338 338 338 2 0.6 0 0% 0 - 100.0 0 - 0 - 2 337 3 1% 0 0%

New Zealand CHL 3 723 3 723 3 535 239 94 39.3 6 3% 0 - 91.5 18 0 3 487 2 095 2 062 23 2 9% 1 4%

Papua New Guinea CPHL 55 55 55 55 1 1.8 1 2% 0 - 62.5 0 - 0 - 1 55 5 9% 1 2%

Philippines RITM 29 333 8 250 8 215 8 219 4 817 58.6 281 3% 31 7 48.2 0 - 2 757 1 939 6 463 3 164 245 8% 94 3%

Republic of Korea KCDC 8 091 8 091 4 969 3 276 186 5.7 91 3% 0 - 56.7 0 - 4 350 281 375 359 57 16% 29 8%

Singapore NPHL 870 870 841 86 20 23.3 3 3% 0 - 95.3 129 49 798 138 207 86 1 1% 2 2%

Viet Nam national lab (Northern) NIHE 1 216 1 216 1 187 974 740 76.0 5 1% 0 - 99.6 183 4 241 192 916 295 9 3% 0 0%

Viet Nam national lab (Southern) PI 4 324 4 324 4 320 4 309 1 864 43.3 14 0% 0 - 53.6 15 0 15 0 1 864 3 509 29 1% 16 0%

Viet Nam subnational lab (Central) PI 1 375 1 375 1 375 1 375 1 242 90.3 9 1% 0 - 53.7 5 0 15 10 1 242 860 0 0% 1 0%

Viet Nam subnational lab (Highland) IHE 1 541 1 541 1 541 1 542 1 396 90.5 11 1% 0 - 50.4 0 - 0 - 1 395 1 028 1 0% 1 0%

Fiji FCCDC 483 472 472 444 28 6.3 14 3% 0 - No data 0 - 9 4 28 201 6 3% 0 0%

Total 87 799 66 551 50 790 38 136 12 738 33. 4 794 2% 110 8 72.2 5 543 129 16 708 5 670 17 605 25 457 2 031 8% 431 2%

"-" No data

Country/area Laboratory

Measles and rubellaMeasles Rubella

Serology Virus detection

Total number of

lab confirmed

cases

Serum and blood (includes DBS)Serum Blood

% of samples

with results ≤4

days

Measles Virus isolation/ detection

(swab, urine and others)

Measles Reverse

Transcription- Polymerase Chain

Reaction

Total number

of samples received

Total number

of samples tested

Total number of cases tested

Samples tested for

measles IgMMeasles IgM (+)

Measles IgM equiv

DBS samples Samples

tested for rubella IgM

Rubella IgM (+)Rubella

IgM equiv

7

Table 6B. Measles and rubella laboratory testing, WHO Western Pacific Region, 2020 as of 20 August 2020

No. No. % No. %No.

receivedNo. (+)

No. of samples tested

No. of isolates

No. of samples tested

No. (+) No. No. % No. %

Australia VIDRL 21 21 20 0 - - - - 0 - - 3 0 21 20 20 0 - - - -

Brunei Darussalam DLS 9 9 9 9 0 0% 0 0% 0 - 95.8 0 - 0 - 0 9 0 0% 0 0%

Cambodia NIPH 1 991 1 991 1 991 1 952 358 18% 0 0% 29 1 94.8 0 - 0 - 368 1 938 18 1% 0 0%

China CCDC - - - - - - - - 0 - 95.8 - - - - - - - - - -

China, Hong Kong SAR PHLC 283 283 220 198 2 1% 0 0% 0 - 94.8 0 - 70 0 2 124 5 4% 1 1%

China, Macao SAR PHL 60 60 45 45 5 11% 1 2% 0 - 100.0 1 0 17 0 5 45 2 4% 0 0%

Japan NIID 643 624 400 52 9 17% 17 33% 0 - - 0 - 188 4 10 95 53 56% 15 16%

Lao People's Democratic Republic NCLE 174 174 174 174 34 20% 11 6% 0 - 73.8 0 - 0 - 34 174 13 7% 6 3%

Malaysia NPHL 7 306 7 306 4 776 4 492 466 10% 108 2% 0 - 86.7 851 0 0 - 466 3 766 172 5% 76 2%

Mongolia NCCD 57 57 57 57 0 0% 0 0% 0 - 100.0 0 - 0 - 0 57 0 0% 0 0%

New Zealand CHL 79 79 76 4 1 25% 0 0% 0 - 75.0 0 - 75 7 7 3 0 - 0 -

Papua New Guinea CPHL 108 108 107 107 6 6% 1 1% 0 - 60.7 0 - 0 - 6 107 1 1% 3 3%

Philippines RITM 2 720 2 473 2 411 2 414 1 054 44% 62 3% 6 1 95.7 0 - 169 54 1 098 1 365 404 30% 31 2%

Republic of Korea KCDC 481 481 313 217 17 8% 5 2% 0 - 92.0 0 - 213 13 21 111 33 30% 6 5%

Singapore NPHL 208 208 196 20 2 10% 1 5% 0 - 85.0 10 1 162 8 11 20 0 0% 0 0%

Viet Nam national lab (Northern) NIHE 49 49 49 49 46 - 0 - 0 - - 0 - 0 - 46 0 - - - -

Viet Nam national lab (Southern) PI 661 661 661 661 459 69% 5 1% 0 - - 0 - 0 - 459 210 22 10% 4 2%

Viet Nam subnational lab (Central) PI 33 33 33 33 20 - 0 - 0 - - 0 - 0 - 20 31 1 - 0 0%

Viet Nam subnational lab (Highland) IHE 1 1 1 1 1 100% 0 0% 0 - - 0 - 0 - 1 0 - - - -

Fiji FCCDC 169 163 163 162 5 3% 8 5% 0 - - 0 - 2 0 5 36 0 0% 0 0%

Total 15 053 14 781 11 702 10 647 2 485 23% 219 2% 35 2 90.6 865 1 917 106 2 579 8 091 724 9% 142 2%

"-" No data

Samples tested for rubella IgM

Rubella IgM (+)Rubella

IgM equivDBS samples

Total number

of samples received

Total number

of samples tested

Total number of cases tested

Samples tested for

measles IgMMeasles IgM (+)

Measles IgM equiv

Virus detection

Total number of

lab confirmed

cases

Serum and blood (includes DBS)Serum Blood

% of samples

with results ≤4

days

Measles Virus isolation/ detection

(swab, urine and others)

Measles Reverse

Transcription- Polymerase Chain

Reaction

Country/area Laboratory

Measles and rubellaMeasles Rubella

Serology

8

Figure 3. Measles genotype distribution of cases with rash onset in 2019 and 2020, WHO Western Pacific Region

Table 7. Measles genotype distribution of cases with rash onset in August 2019 to July 2020, WHO Western Pacific Region

2019 2020

B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1 B3 D8 D9 H1Australia 8 5 2 8 3 7 1 2 3 12 4 1Brunei Darussalam 1CambodiaChina 11 14 10 1 3 11 1 3 10 14 3China, Hong Kong SAR 1 1 1 2 1China, Macao SARJapan 8 2 1 3 1 2 1 1Lao People's Democratic RepublicMalaysiaMongoliaNew Zealand 16 42 14 47 1 36 11 18 6 3 2 1Papua New GuineaPhilippines 45Republic of Korea 6 11 2 3 2 1Singapore 7 2 2 3 1 2 2 2 1Viet Nam 5 1 1 11 15Pacific island countries and areas 3 3

Sep Oct Nov Dec2019

Jan2020

Feb Mar AprAug May Jun JulCountry/area

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 August 2020

The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved.

9

Figure 4. Rubella genotype distribution of cases with rash onset in 2019 and 2020, WHO Western Pacific Region

Table 8. Rubella genotype distribution of cases with rash onset in August 2019 to July 2020, WHO Western Pacific Region

2019 2020

Source: Measles and rubella monthly country reports to the Western Pacific Regional Office by 20 August 2020

2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J 2B 1E 1J

Australia

Brunei Darussalam

Cambodia

China 16 20 10 19 24 13 2 13 7 8 20 27 2 8China, Hong Kong SAR 2 1 1 1 1 1China, Macao SAR

Japan 25 1 12 7 1 3 4 3 5 2 5 3Lao People's Democratic Republic

Malaysia

Mongolia

New Zealand

Papua New Guinea

Philippines

Republic of Korea 1 1 1Singapore 1 1 1Viet Nam

Pacific island countries and areas

2019

OctAug

2020

Sep AprNov Dec Jan Mar May Jun JulFebCountry/area

The boundaries and names shown and the designations used on the maps do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO Regional Office for the Western Pacific 2020. All rights reserved.

Table 9A. Completeness and timeliness of epidemiologic reporting, WHO Western Pacific Region, 2019—2020

Table 9B. Completeness and timeliness of laboratory reporting, WHO Western Pacific Region, 2019—2020

Vaccine-Preventable Diseases and Immunization Regional Office for the Western Pacific

World Health Organization

P.O. Box 2932, 1000 Manila, PhilippinesTel. No. (63 2) 85288001

Fax No. (63 2) 85211036, 85260279Please send your comments and monthly data before the 10th of the month to: WPROEPIdata@who.int

More detailed information available in theRegional and country profile of measles elimination

Jan Feb Mar Apr May Jun Jul

Australia 100% 92% 10 Feb 17 Mar 07 Apr 10 May 09 Jun 10 Jul 10 Aug 86% 86%

Brunei Darussalam 100% 100% 06 Feb 02 Mar 04 Apr 07 May 06 Jun 06 Jul 04 Aug 86% 100%

Cambodia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

China 100% 33% 15 Feb 17 Mar 03 Apr 05 May 01 Jun 03 Jul 03 Aug 86% 100%

China, Hong Kong SAR 92% 92% 07 Feb 06 Mar 08 Apr 06 May 04 Jun 07 Jul 05 Aug 86% 100%

China, Macao SAR 100% 100% 10 Feb 09 Mar 08 Apr 07 May 08 Jun 08 Jul 05 Aug 86% 100%

Japan 100% 67% 11 Feb 23 Mar 29 Apr - 13 Jun 19 Jul 11 Aug 71% 0%

Lao People's Democratic Republic 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

Malaysia 100% 83% 10 Feb 09 Mar 06 Apr 06 May 06 Jun 03 Jul 11 Aug 86% 86%

Mongolia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

New Zealand 100% 100% 10 Feb 10 Mar 08 Apr 08 May 09 Jun 08 Jul 03 Aug 86% 100%

Papua New Guinea 75% 25% 10 Feb 10 Mar 08 Apr 09 May 10 Jun 10 Jul 10 Aug 86% 100%

Philippines 67% 17% 19 Feb 13 Mar 28 Apr 10 May 22 Jun 10 Jul 03 Aug 86% 57%

Republic of Korea 92% 33% 10 Feb 10 Mar 10 Apr 10 May 08 Jun 07 Jul 05 Aug 86% 100%

Singapore 100% 100% 10 Feb 09 Mar 07 Apr 08 May 06 Jun 06 Jul 05 Aug 86% 100%

Viet Nam 92% 92% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

Pacific island countries and areas 100% 92% 14 Feb 13 Mar 14 Apr 14 May 12 Jun 15 Jul 14 Aug 86% 100%

Completeness 95% 100% 100% 100% 94% 100% 100% 100% 99%

Timeliness 78% 88% 82% 88% 94% 88% 94% 88% 90%1 National measles surveillance monthly reports from July 2020. Legend: black = timely report; red = untimely report

3 Countries and areas should submit reports by the 10th (or the next working day) of the following month; Pacific island countries and areas and China may report to the Regional Office by the 15th (or the next working day) of the following month.

2020 1

2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.

Completeness 2 Timeliness 3Country

2019

Completeness 2 Timeliness 3

Australia 100% 92% 07 Feb 06 Mar 01 Apr 04 May 01 Jun 03 Jul 04 Aug 86% 86%

Brunei Darussalam 100% 100% 07 Feb 02 Mar 02 Apr 02 May 06 Jun 04 Jul 30 Jul 86% 86%

Cambodia 100% 108% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 86%

China 100% 100% 06 Feb 02 Mar 01 Apr 06 May 06 Jun 03 Jul 07 Aug 86% 100%

China, Hong Kong SAR 100% 100% 07 Feb 06 Mar 08 Apr 06 May 04 Jun 07 Jul 06 Aug 86% 100%

China, Macao SAR 100% 100% 10 Feb 10 Mar 10 Apr 08 May 09 Jun 09 Jul 06 Aug 86% 100%

Japan 100% 58% 11 Feb 23 Mar 29 Apr - 13 Jun 19 Jul 11 Aug 71% 0%

Lao People's Democratic Republic 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

Malaysia 100% 83% 12 Feb 11 Mar 08 Apr 08 May 05 Jun 07 Jul 06 Aug 86% 71%

Mongolia 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

New Zealand 100% 100% 10 Feb 10 Mar 08 Apr 08 May 09 Jun 08-Jul 03 Aug 86% 100%

Papua New Guinea 75% 67% 06 Feb 10 Mar - - - 08 Jul - 43% 43%

Philippines 92% 83% 10 Feb 10 Mar 10 Apr 10 May 12 Jun 10 Jul 10 Aug 86% 86%

Republic of Korea 100% 100% 10 Feb 10 Mar 10 Apr 08 May 11 Jun 10 Jul 07 Aug 86% 86%

Singapore 100% 100% 09 Feb 09 Mar 07 Apr 08 May 06 Jun 06 Jul 05 Aug 86% 100%

Viet Nam national lab (Northern) 100% 92% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

Viet Nam national lab (Southern) 100% 100% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

Viet Nam subnational lab (Central) 100% 92% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

Viet Nam subnational lab (Highland) 100% 92% 10 Feb 10 Mar 10 Apr 10 May 10 Jun 10 Jul 10 Aug 86% 100%

Fiji 100% 92% 15 Feb 13 Mar 14 Apr 14 May 12 Jun 15 Jul 14 Aug 86% 100%

Completeness 98% 100% 100% 95% 90% 95% 100% 95% 96%

Timeliness 92% 85% 90% 90% 90% 80% 95% 90% 87%1 National measles laboratory monthly reports from July 2020.

2 Completeness is defined as the number of reports received by the end of the reporting month divided by the number of expected reports for the year.

3 National measles and rubella laboratories should submit monthly reports by the 10th (or the next working day) of the following month.

2020 1

Country/area

2019

Completeness 2 Timeliness 3 May Jun JulJan Feb Mar Apr Completeness 2 Timeliness 3